Japan health ministry panel approves Moderna COVID vaccine for ages 12-17

A Japanese health ministry panel on Monday approved Moderna Inc.'s COVID-19 vaccine for ages 12 to 17, clearing the way for it to become the second shot available to adolescents in the country after the one developed by Pfizer Inc.The Ministry of Health, Labor and Welfare is expected to decide at a later date to provide the Moderna vaccine free of charge to the age group as part of the government's nationwide vaccination program.Among the more than 3,700 subjects aged 12 to 17 who took part in clinical trials in the United States, none developed signs of COVID-19 within 14 days of receiving…READ FULL ARTICLE